Innovation drugs

JSC «Medvax» Ltd is an authorized supplier of innovation drugs to Belarus:

 
Avastin (Bevacizumab) (A humanized monoclonal antibody, a proven treatment for metastatic colorectal cancer, lung cancer, breast cancer)

Actemra (Tocilizumab) (Innovative drug (a monoclonal antibody) for the treatment of rheumatoid arthritis)

— Gazyva (Obinutuzumab)

Herceptin (Trastuzumab) (A treatment for breast cancer)

— Zelboraf (Vemurafenib)

— Kadcyla (Trastuzumab)

Xeloda (Capecitabine) (A modern cytotoxic drug for oral chemotherapy, provides cancer treatment for metastatic breast cancer and colorectal cancer, as well as adjuvant therapy for Stage III (Dukes’ C) colon cancer after surgery)

— Mabthera (Rituximab)

— Perjeta (Pertuzumab)

— Pulmozyme (Dornase alfa)

— Revolade (Eltrombopag)

— Tasigna (Nilotinib)

— Sandostatin LAR (Octreotide)

— Exjade (Deferasirox)